BT-50 Main target antigen for atypical pANCA for use in diagnostic tests

Scientists at the University of Bonn, Germany, have identified the main target antigen for the atypical antineutrophil

cytoplasmic antibodies pANCA in autoimmune liver disorders and chronic inflammatory bowel diseases. BT-50 can be produced by recombinant means and used for the quantification of atypical pANCA in serum probes.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Enhancing the workhorse

Artificial intelligence, hardware innovations boost confocal microscope’s performance. Since artificial intelligence pioneer Marvin Minsky patented the principle of confocal microscopy in 1957, it has become the workhorse standard in life…

In the quantum realm, not even time flows as you might expect

New study shows the boundary between time moving forward and backward may blur in quantum mechanics. A team of physicists at the Universities of Bristol, Vienna, the Balearic Islands and…

Hubble Spots a Swift Stellar Jet in Running Man Nebula

A jet from a newly formed star flares into the shining depths of reflection nebula NGC 1977 in this Hubble image. The jet (the orange object at the bottom center…

Partners & Sponsors